Mucobene (Acetylcysteine)

Acetylcysteine breaks disulfide bonds in mucus glycoproteins, which reduces the thickness and stickiness of mucus. This chemical modification lowers viscosity, allowing cilia in the airways to move mucus more effectively toward the throat for clearance. The drug also replenishes glutathione, providing antioxidant support to airway cells.

The appropriate dose of Mucobene is determined by the prescribing clinician based on the patient’s age, condition severity, and renal function. Healthcare professionals follow local guidelines and adjust the regimen as needed; patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety data for acetylcysteine in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss use with their healthcare provider.

To request Mucobene, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs), and import documentation.

Mucobene’s acetylcysteine differs from agents such as carbocisteine or bromhexine by directly cleaving disulfide bonds, which can produce a faster reduction in mucus viscosity. While all mucolytics aim to improve clearance, acetylcysteine also supplies cysteine for glutathione synthesis, offering additional antioxidant benefits.

Mucobene should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging to protect them from moisture and light. Do not store in areas with high humidity or direct sunlight, and keep out of reach of children.

Mucobene is taken orally as a tablet. The tablet should be swallowed whole with a glass of water, and it can be taken with or without food according to the prescriber’s guidance. Patients should not crush or chew the tablet unless specifically instructed.

The most serious adverse reactions include severe allergic responses such as rash, urticaria, bronchospasm, or anaphylaxis, and rare cases of significant hypotension or liver enzyme elevation. Immediate medical attention is required if any signs of a serious reaction appear.

Mucobene should be avoided in individuals with known hypersensitivity to acetylcysteine or any excipients in the tablet. Patients with severe uncontrolled asthma, a history of bronchospasm triggered by mucolytics, or those with significant renal impairment should consult their physician before use.